These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23251630)

  • 1. ECG marker of adverse electrical remodeling post-myocardial infarction predicts outcomes in MADIT II study.
    Tereshchenko LG; McNitt S; Han L; Berger RD; Zareba W
    PLoS One; 2012; 7(12):e51812. PubMed ID: 23251630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular arrhythmia is predicted by sum absolute QRST integralbut not by QRS width.
    Tereshchenko LG; Cheng A; Fetics BJ; Marine JE; Spragg DD; Sinha S; Calkins H; Tomaselli GF; Berger RD
    J Electrocardiol; 2010; 43(6):548-52. PubMed ID: 20832820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECG quantification of myocardial scar and risk stratification in MADIT-II.
    Loring Z; Zareba W; McNitt S; Strauss DG; Wagner GS; Daubert JP
    Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):427-35. PubMed ID: 24047486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel measure of electrical dyssynchrony predicts response in cardiac resynchronization therapy: Results from the SMART-AV Trial.
    Tereshchenko LG; Cheng A; Park J; Wold N; Meyer TE; Gold MR; Mittal S; Singh J; Stein KM; Ellenbogen KA;
    Heart Rhythm; 2015 Dec; 12(12):2402-10. PubMed ID: 26272523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline adverse electrical remodeling and the risk for ventricular arrhythmia in Cardiac Resynchronization Therapy Recipients (MADIT CRT).
    Biton Y; Ng CY; Xia X; Baman JR; Couderc JP; Moss AJ; Kutyifa V; McNitt S; Polonsky B; Zareba W
    J Cardiovasc Electrophysiol; 2018 Jul; 29(7):1017-1023. PubMed ID: 29846992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic Changes in High-Sensitivity Cardiac Troponin I Are Associated with Dynamic Changes in Sum Absolute QRST Integral on Surface Electrocardiogram in Acute Decompensated Heart Failure.
    Tereshchenko LG; Feeny A; Shelton E; Metkus T; Stolbach A; Mavunga E; Putman S; Korley FK
    Ann Noninvasive Electrocardiol; 2017 Jan; 22(1):. PubMed ID: 27265641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the Sum Absolute QRST Integral to Predict Outcomes in Patients Receiving Cardiac Resynchronization Therapy.
    Jacobsson J; Borgquist R; Reitan C; Ghafoori E; Chatterjee NA; Kabir M; Platonov PG; Carlson J; Singh JP; Tereshchenko LG
    Am J Cardiol; 2016 Aug; 118(3):389-95. PubMed ID: 27265674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Dhar R; Alsheikh-Ali AA; Estes NA; Moss AJ; Zareba W; Daubert JP; Greenberg H; Case RB; Kent DM
    Heart Rhythm; 2008 Jun; 5(6):807-13. PubMed ID: 18534364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arrhythmias during remodeling after myocardial infarction].
    Bauer WR; Ertl G
    Herz; 2002 Dec; 27(8):740-9. PubMed ID: 12574891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.
    Waks JW; Hamilton C; Das S; Ehdaie A; Minnier J; Narayan S; Niebauer M; Raitt M; Tompkins C; Varma N; Chugh S; Tereshchenko LG
    J Interv Card Electrophysiol; 2018 Jun; 52(1):77-89. PubMed ID: 29541969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.
    Sesselberg HW; Moss AJ; McNitt S; Zareba W; Daubert JP; Andrews ML; Hall WJ; McClinitic B; Huang DT;
    Heart Rhythm; 2007 Nov; 4(11):1395-402. PubMed ID: 17954398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients.
    Goldenberg I; Aktas MK; Zareba W; Tsu-Chau Huang D; Rosero SZ; Younis A; McNitt S; Stockburger M; Steinberg JS; Buttar RS; Merkely B; Kutyifa V
    JACC Clin Electrophysiol; 2024 Jan; 10(1):16-26. PubMed ID: 38032575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
    Rosenthal TM; Stahls PF; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Xue JQ; Morin DP
    Heart Rhythm; 2015 Aug; 12(8):1789-97. PubMed ID: 25998895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new electrocardiogram marker to identify patients at low risk for ventricular tachyarrhythmias: sum magnitude of the absolute QRST integral.
    Tereshchenko LG; Cheng A; Fetics BJ; Butcher B; Marine JE; Spragg DD; Sinha S; Dalal D; Calkins H; Tomaselli GF; Berger RD
    J Electrocardiol; 2011; 44(2):208-16. PubMed ID: 21093871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of sudden and non-sudden cardiac death in post-infarction patients with reduced left ventricular ejection fraction by periodic repolarization dynamics: MADIT-II substudy.
    Rizas KD; McNitt S; Hamm W; Massberg S; Kääb S; Zareba W; Couderc JP; Bauer A
    Eur Heart J; 2017 Jul; 38(27):2110-2118. PubMed ID: 28431133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Haigney MC; Zareba W; Gentlesk PJ; Goldstein RE; Illovsky M; McNitt S; Andrews ML; Moss AJ;
    J Am Coll Cardiol; 2004 Oct; 44(7):1481-7. PubMed ID: 15464332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score.
    Younis A; Goldberger JJ; Kutyifa V; Zareba W; Polonsky B; Klein H; Aktas MK; Huang D; Daubert J; Estes M; Cannom D; McNitt S; Stein K; Goldenberg I
    Eur Heart J; 2021 May; 42(17):1676-1684. PubMed ID: 33417692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.